Literature DB >> 11191838

Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors.

G Sacchetti1, M Bernini, M Gobbi, S Parini, L Pirona, T Mennini, R Samanin.   

Abstract

Adaptive phenomena such as desensitization of autoreceptors are considered an important factor in the achievement of therapeutic efficacy of antidepressant drugs after chronic treatment. We have studied whether a chronic treatment with desipramine had a greater effect than a single dose on the extracellular concentrations of noradrenaline in the dorsal hippocampus. Administration of 10 mg/kg i.p. desipramine once daily for 14 days significantly raised the basal extracellular noradrenaline in the dorsal hippocampus 24 h but not 48 h after the last drug injection. A challenge dose of desipramine increased extracellular noradrenaline in rats treated chronically with vehicle and desipramine. The effect was significantly higher in rats treated chronically with desipramine 48 h but not 24 h after the last injection. An intraperitoneal administration of the alpha2-adrenoceptor agonist clonidine at the dose of 10 microg/kg significantly reduced extracellular noradrenaline in the control group but not in animals chronically treated with desipramine whereas 30 microg/kg clonidine produced a similar decrease in both groups. Three concentrations of clonidine (0.05, 0.5 and 1 microM) infused into the hippocampus significantly reduced extracellular noradrenaline to a similar extent in rats chronically treated with saline or desipramine. Fourty-eight hours after the last injection of the chronic treatment, [3H]RX-821002 binding to alpha2-adrenoceptors in the rat locus coeruleus measured by autoradiography was not significantly modified. A slight (17%) but significant decrease of neuronal uptake of [3H]noradrenaline was found in synaptosome preparations from dorsal hippocampus of rats chronically treated with desipramine, but this was likely due to a decrease in affinity. The results suggest that a repeated treatment with desipramine (10 mg/kg i.p. once daily for 14 days) facilitates its effect on extracellular noradrenaline in the dorsal hippocampus and induces adaptive changes probably involving desensitization of alpha2-adrenoceptors, with no changes in their density, on noradrenergic neurons in the locus coeruleus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11191838     DOI: 10.1007/s002100000334

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss.

Authors:  Mark E Bardgett; Megan Points; Christian Ramsey-Faulkner; Jeff Topmiller; John Roflow; Travis McDaniel; Timberly Lamontagne; Molly S Griffith
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

2.  Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.

Authors:  R W Invernizzi; S Parini; G Sacchetti; C Fracasso; S Caccia; K Annoni; R Samanin
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

4.  The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.

Authors:  Christopher Cottingham; Yunjia Chen; Kai Jiao; Qin Wang
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

5.  Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study.

Authors:  Y Mateo; B Fernández-Pastor; J J Meana
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Differential modulation of α-1 adrenoceptor subtypes by antidepressants in the rat brain.

Authors:  D Ramakrishna; M N Subhash
Journal:  J Neural Transm (Vienna)       Date:  2010-12-07       Impact factor: 3.575

Review 7.  Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?

Authors:  David B Bylund; Abbey L Reed
Journal:  Neurochem Int       Date:  2007-06-30       Impact factor: 3.921

8.  Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine.

Authors:  Zaorui Zhao; Alicia M Baros; Han-Ting Zhang; M Danet S Lapiz; Corina O Bondi; David A Morilak; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

Review 9.  Environmental and Pharmacological Modulation of Amphetamine- Induced 50-kHz Ultrasonic Vocalizations in Rats.

Authors:  Henrike Rippberger; Marcel M van Gaalen; Rainer K W Schwarting; Markus Wohr
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  Effects of psychotropic agents on extinction of lever-press avoidance in a rat model of anxiety vulnerability.

Authors:  Xilu Jiao; Kevin D Beck; Amanda L Stewart; Ian M Smith; Catherine E Myers; Richard J Servatius; Kevin C H Pang
Journal:  Front Behav Neurosci       Date:  2014-09-15       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.